µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease

Parkinson's disease (PD) is characterized by severe locomotor deficits and is commonly treated with the dopamine precursor L-DOPA, but its prolonged usage causes dyskinesias referred to as L-DOPA–induced dyskinesia (LID). Several studies in animal models of PD have suggested that dyskinesias ar...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Neurosci
Main Authors: Bezard, Erwan, Li, Qin, Hulme, Heather, Fridjonsdottir, Elva, Nilsson, Anna, Pioli, Elsa, Andren, Per E., Crossman, Alan R.
Formato: Artigo
Idioma:Inglês
Publicado: Society for Neuroscience 2020
Assuntos:
Research Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7455220/
https://ncbi.nlm.nih.gov/pubmed/32690616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.0610-20.2020
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares